|
Contrast agent 5-year sales forecast looks positive
 September 13, 2012 -- The market for contrast agents and radiopharmaceuticals is expected to grow over the next few years, with much of that growth coming from MRI, ultrasound, and nuclear medicine, according to a new report published by Kalorama Information.
To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
| |
|
|
New AuntMinnie.com Members
|
Becoming a Member is FREE!
|
Real-time radiology-specific news
Case of the Day and Teaching Files
Focused topics digital communities
Lively, discussion groups
Medical imaging bookstore
SalaryScan
Job Boards
OnLine CMe/CE
Bookstore, market reports, more …
Conference Calendar
User-controlled eNewsletters
… registration is FREE and easy!
|
| |
|
The report, "Medical Imaging Markets: Contrast Agents," finds that annual growth for medical contrast media will continue over the next five years, despite the slump in capital equipment purchases. Imaging exams are still needed for making many diagnoses, and contrast facilitates diagnosis in many cases, the company said.
The contrast market reached $3.5 billion in 2011; Kalorama predicts yearly growth rates for contrast agents used with most modalities to range from 2% to 4%. | |
|